Literature DB >> 9952242

Myasthenia gravis: another autoimmune disease associated with hepatitis C virus infection.

S Eddy1, R Wim, V E Peter, R Tanja, T Jan, V S Werner.   

Abstract

We report on a male Egyptian patient who developed myasthenia gravis with typical symptoms, beneficial response to pyridostigmine, and the presence of anti-acetylcholine receptor antibodies and anti-striated muscle antibodies during the course of a chronic hepatitis C infection complicated by liver cirrhosis. As also reported for the herpes simplex and for the HIV virus, hepatitis C may lead to myasthenia gravis via a mechanism of cross-reactivity between viral epitopes and the acetylcholine receptor.

Entities:  

Mesh：

Substances：

Year:  1999        PMID： 9952242     DOI： 10.1023/a:1026683007277

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN： 0163-2116            Impact factor:   3.199


  31 in total

1.  Autoimmune chronic hepatitis type 2 manifested during interferon therapy in children.

Authors:  M Ruiz-Moreno; M J Ruá; V Carreño; J A Quiroga; M Manns; K H Meyer zum Büschenfelde
Journal:  J Hepatol       Date:  1991-03       Impact factor: 25.083

2.  Sharing of antigenic determinants between the nicotinic acetylcholine receptor and proteins in Escherichia coli, Proteus vulgaris, and Klebsiella pneumoniae. Possible role in the pathogenesis of myasthenia gravis.

Authors:  K Stefansson; M E Dieperink; D P Richman; C M Gomez; L S Marton
Journal:  N Engl J Med       Date:  1985-01-24       Impact factor: 91.245

Review 3.  Mechanisms of action of interferons.

Authors:  M Peters
Journal:  Semin Liver Dis       Date:  1989-11       Impact factor: 6.115

Review 4.  Side effects of alpha interferon.

Authors:  P F Renault; J H Hoofnagle
Journal:  Semin Liver Dis       Date:  1989-11       Impact factor: 6.115

5.  Acute exacerbation of liver disease during interferon alfa therapy for chronic hepatitis C.

Authors:  M Shindo; A M Di Bisceglie; J H Hoofnagle
Journal:  Gastroenterology       Date:  1992-04       Impact factor: 22.682

6.  Sustained hypothyroidism induced by recombinant alpha interferon in patients with chronic hepatitis C.

Authors:  P Marcellin; M Pouteau; P Renard; J M Grynblat; N Colas Linhart; P Bardet; B Bok; J P Benhamou
Journal:  Gut       Date:  1992-06       Impact factor: 23.059

7.  Molecular mimicry and myasthenia gravis. An autoantigenic site of the acetylcholine receptor alpha-subunit that has biologic activity and reacts immunochemically with herpes simplex virus.

Authors:  P L Schwimmbeck; T Dyrberg; D B Drachman; M B Oldstone
Journal:  J Clin Invest       Date:  1989-10       Impact factor: 14.808

8.  Liver/kidney microsome antibody type 1 and hepatitis C virus infection.

Authors:  F Lunel; N Abuaf; L Frangeul; P Grippon; M Perrin; Y Le Coz; D Valla; E Borotto; A M Yamamoto; J M Huraux
Journal:  Hepatology       Date:  1992-09       Impact factor: 17.425

9.  Anti-GOR and hepatitis C virus in autoimmune liver diseases.

Authors:  G Michel; A Ritter; G Gerken; K H Meyer zum Büschenfelde; R Decker; M P Manns
Journal:  Lancet       Date:  1992-02-01       Impact factor: 79.321

10.  Detection of hepatitis C virus antigen by immuno-histochemical staining: a histological marker of hepatitis C virus infection.

Authors:  S H Yap; M Willems; J Van den Oord; W Habets; J M Middeldorp; J A Hellings; F Nevens; H Moshage; V Desmet; J Fevery
Journal:  J Hepatol       Date:  1994-02       Impact factor: 25.083
View more
  8 in total

Review 1.  Exploring the Gut Microbiome in Myasthenia Gravis.

Authors:  Angel Yun-Kuan Thye; Jodi Woan-Fei Law; Loh Teng-Hern Tan; Sivakumar Thurairajasingam; Kok-Gan Chan; Vengadesh Letchumanan; Learn-Han Lee
Journal:  Nutrients       Date:  2022-04-14       Impact factor: 6.706

Review 2.  Myasthenia gravis and infectious disease.

Authors:  Nils Erik Gilhus; Fredrik Romi; Yu Hong; Geir Olve Skeie
Journal:  J Neurol       Date:  2018-01-25       Impact factor: 4.849

Review 3.  Mechanisms of lymphatic system-specific viral replication and its potential role in autoimmune disease.

Authors:  S-K Friedrich; P A Lang; J Friebus-Kardash; V Duhan; J Bezgovsek; K S Lang
Journal:  Clin Exp Immunol       Date:  2019-01       Impact factor: 4.330

4.  A Systematic Review of the Potential Implication of Infectious Agents in Myasthenia Gravis.

Authors:  Victoria Leopardi; Yu-Mei Chang; Andrew Pham; Jie Luo; Oliver A Garden
Journal:  Front Neurol       Date:  2021-06-14       Impact factor: 4.003

Review 5.  Cryoglobulinemia related to hepatitis C virus infection.

Authors:  Maria Pina Dore; Giovanna Fattovich; Antonia R Sepulveda; Giuseppe Realdi
Journal:  Dig Dis Sci       Date:  2007-02-16       Impact factor: 3.487

6.  The HLA Region and Autoimmune Disease: Associations and Mechanisms of Action.

Authors:  S C L Gough; M J Simmonds
Journal:  Curr Genomics       Date:  2007-11       Impact factor: 2.236

Review 7.  TLR Agonists as Modulators of the Innate Immune Response and Their Potential as Agents Against Infectious Disease.

Authors:  Edin J Mifsud; Amabel C L Tan; David C Jackson
Journal:  Front Immunol       Date:  2014-03-03       Impact factor: 7.561

8.  Myasthenia Crisis Induced by Pegylated-Interferon in Patient With Chronic Hepatitis C: A Case Report.

Authors:  Su Jung Baik; Tae Hun Kim; Hye In Kim; Jeong Yeon Rhie
Journal:  Medicine (Baltimore)       Date:  2016-05       Impact factor: 1.889
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.